Furthermore, 2-aminopyridine-4-carboxamide (2-APQC), an activator of SIRT3, significantly attenuates myocardial fibrosis by inhibiting the JNK pathway and enhancing mitochondrial function [48]. Here, SIRT3 is linked to Myocardial fibrosis.